Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Endurant CHevAr New Indication Trial: ENCHANT

NCT: NCT03320252 · ACTIVE_NOT_RECRUITING

NCT IDNCT03320252
StatusACTIVE_NOT_RECRUITING
Start Date2017-10-26
Completion2030-07
SponsorMedtronic Cardiovascular (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of the post-market study is to assess the clinical outcomes, safety, and performance of the Endurant Chimney Graft Technique (Endurant Stent Graft Systems used with a balloon-expandable covered stent graft) for treatment of juxtarenal aortic aneurysms with a short infrarenal neck in a real world setting.

Frequently Asked Questions

What is Endurant CHevAr New Indication Trial: ENCHANT?

Endurant CHevAr New Indication Trial: ENCHANT is a clinical trial registered under NCT03320252. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03320252?

The current status of NCT03320252 (Endurant CHevAr New Indication Trial: ENCHANT) is: ACTIVE_NOT_RECRUITING.

When did Endurant CHevAr New Indication Trial: ENCHANT start?

Endurant CHevAr New Indication Trial: ENCHANT started on 2017-10-26.

Related Devices

PMA P250055Hybrid stent graft, thoracic aortic lesion treatmentArtivion, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑